Perspective Therapeutics annual gross margin
2016
2017
2018
2019
2020
2021
2022
2023
Perspective Therapeutics Gross Margin Growth & History (CATX)
Perspective Therapeutics's gross margin was 100.00% for fiscal 2023.
View full Perspective Therapeutics company overviewPerspective Therapeutics annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2023 | 2023-12-31 | 100.00% | +100.00 pp |
| 2022 | 2022-06-30 | 0.00% | −50.94 pp |
| 2021 | 2021-06-30 | 50.94% | −1.99 pp |
| 2020 | 2020-06-30 | 52.93% | +11.27 pp |
| 2019 | 2019-06-30 | 41.66% | +10.56 pp |
| 2018 | 2018-06-30 | 31.10% | +13.50 pp |
| 2017 | 2017-06-30 | 17.60% | +14.90 pp |
| 2016 | 2016-06-30 | 2.70% | — |
Perspective Therapeutics quarterly gross margin
Q3.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q3.23
Q2.23
Q3.23
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q3 2023 · Sep 30 | 2023-09-30 | 38.66% | +1.69 pp |
| Q2 2023 | 2023-06-30 | 16.53% | −32.99 pp |
| Q3 2023 · Mar 31 | 2023-03-31 | 26.61% | −16.71 pp |
| Q1 2023 | 2022-09-30 | 24.11% | −16.02 pp |
| Q4 2022 | 2022-06-30 | 36.97% | −12.70 pp |
| Q3 2022 | 2022-03-31 | 49.52% | −2.87 pp |
| Q2 2022 | 2021-12-31 | 43.32% | −6.15 pp |
| Q1 2022 | 2021-09-30 | 40.13% | −12.13 pp |
| Q4 2021 | 2021-06-30 | 49.67% | +2.67 pp |
| Q3 2021 | 2021-03-31 | 52.38% | −6.85 pp |
| Q2 2021 | 2020-12-31 | 49.47% | −0.89 pp |
| Q1 2021 | 2020-09-30 | 52.27% | −1.13 pp |
| Q4 2020 | 2020-06-30 | 46.99% | +1.31 pp |
| Q3 2020 | 2020-03-31 | 59.24% | +13.55 pp |
| Q2 2020 | 2019-12-31 | 50.36% | +10.18 pp |
| Q1 2020 | 2019-09-30 | 53.39% | +19.84 pp |
| Q4 2019 | 2019-06-30 | 45.69% | +18.42 pp |
| Q3 2019 | 2019-03-31 | 45.69% | +6.97 pp |
| Q2 2019 | 2018-12-31 | 40.18% | +5.61 pp |
| Q1 2019 | 2018-09-30 | 33.55% | +11.66 pp |
| Q4 2018 | 2018-06-30 | 27.26% | +4.41 pp |
| Q3 2018 | 2018-03-31 | 38.72% | — |
| Q2 2018 | 2017-12-31 | 34.57% | — |
| Q1 2018 | 2017-09-30 | 21.88% | — |
| Q3 2017 | 2017-03-31 | 22.85% | — |
Perspective Therapeutics gross margin trends
Over the last five reported fiscal years, Perspective Therapeutics's gross margin increased from 31.10% to 100.00%, a change of +68.90 percentage points. The latest reported quarter, Q3 2023 · Sep 30, shows 38.66%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Perspective Therapeutics filings at SEC.gov ↗